Table 1.
Summary of the available evaluation (ZURICH and DRESDEN) and training (Rou2 and PhIng) data with number of cases (BL, FU pairs) with and without new or enlarged lesions, mean new or enlarged lesion count per case, mean lesion size and mean time between the two scans (BL and FU). For the DRESDEN data the values for an additional evaluation between time point one and four are also given (DRESDEN 1-4).
| Sets | #cases | #new/enl. lesions | #new/enl. Lesion per case | lesion size | follow-up time | |
|---|---|---|---|---|---|---|
| Training sets: | ||||||
| Rou2 (without SIEM. | all cases | 1444 | 2447 | 1.69 (±4.59) | 1.16 (±0.60) yr. | |
| Verio, Ph. Ingenia) | cases with > 1 lesion | 614 | 2447 | 3.98 (±6.36) | 0.18 (±0.54) ml | |
| PhIng (Ph. Ingenia) | all cases | 130 | 288 | 2.21 (±5.60) | 0.98 (±0.38) yr. | |
| cases with > 1 lesion | 55 | 288 | 5.23 (±7.68) | 0.19 (±0.50) ml | ||
| Evaluation sets: | ||||||
| ZURICH | all cases | 89 | 209 | 2.34 (±4.44) | 2.24 (±1.17) yr. | |
| (Ph. Ingenia) | cases with > 1 lesion | 51 | 209 | 4.09 (±5.23) | 0.13 (±0.14) ml | |
| DRESDEN | all cases | 96 | 157 | 1.67 (±2.49) | 1.01 (±0.08) yr. | |
| (SIEM. Verio) | cases with > 1 lesion | 53 | 157 | 2.96 (±2.69) | 0.13 (±0.18) ml | |
| DRESDEN 1–4 | all cases | 32 | 108 | 3.36 (±3.74) | 3.02 (±0.12) yr. | |
| (SIEM. Verio) | cases with > 1 lesion | 26 | 108 | 4.13 (±3.75) | 0.12 (±0.19) ml | |